universal health services inc. - UHS

UHS

Close Chg Chg %
185.09 -1.09 -0.59%

Closed Market

184.00

-1.09 (0.59%)

Volume: 581.11K

Last Updated:

Mar 27, 2026, 3:59 PM EDT

Company Overview: universal health services inc. - UHS

UHS Key Data

Open

$185.09

Day Range

183.57 - 185.71

52 Week Range

152.33 - 246.19

Market Cap

$11.31B

Shares Outstanding

61.09M

Public Float

51.22M

Beta

1.26

Rev. Per Employee

N/A

P/E Ratio

8.01

EPS

$23.47

Yield

43.22%

Dividend

$0.20

EX-DIVIDEND DATE

Mar 2, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

820.13K

 

UHS Performance

1 Week
 
-0.39%
 
1 Month
 
-10.19%
 
3 Months
 
-18.69%
 
1 Year
 
-0.59%
 
5 Years
 
36.95%
 

UHS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About universal health services inc. - UHS

Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.

UHS At a Glance

Universal Health Services, Inc.
Universal Corporate Center
King of Prussia, Pennsylvania 19406-3121
Phone 1-610-768-3300 Revenue 17.36B
Industry Hospital/Nursing Management Net Income 1.49B
Sector Health Services 2025 Sales Growth 9.71%
Fiscal Year-end 12 / 2026 Employees 101,500
View SEC Filings

UHS Valuation

P/E Current 8.014
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 9.44
Price to Sales Ratio 0.809
Price to Book Ratio 1.83
Price to Cash Flow Ratio 7.54
Enterprise Value to EBITDA 7.355
Enterprise Value to Sales 1.107
Total Debt to Enterprise Value 0.269

UHS Efficiency

Revenue/Employee 171,082.059
Income Per Employee 14,667.941
Receivables Turnover 6.673
Total Asset Turnover 1.127

UHS Liquidity

Current Ratio 1.052
Quick Ratio 0.98
Cash Ratio 0.043

UHS Profitability

Gross Margin 11.483
Operating Margin 11.483
Pretax Margin 11.357
Net Margin 8.574
Return on Assets 9.664
Return on Equity 21.357
Return on Total Capital 11.966
Return on Invested Capital 12.874

UHS Capital Structure

Total Debt to Total Equity 71.009
Total Debt to Total Capital 41.524
Total Debt to Total Assets 32.377
Long-Term Debt to Equity 59.72
Long-Term Debt to Total Capital 34.922
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Universal Health Services Inc. - UHS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
13.40B 14.28B 15.83B 17.36B
Sales Growth
+5.99% +6.59% +10.82% +9.71%
Cost of Goods Sold (COGS) incl D&A
12.34B 13.11B 14.15B 15.37B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
581.86M 568.04M 584.83M 618.74M
Depreciation
544.00M 535.60M 559.60M 594.00M
Amortization of Intangibles
37.86M 32.44M 25.23M 24.74M
COGS Growth
+9.53% +6.23% +7.93% +8.66%
Gross Income
1.06B 1.18B 1.68B 1.99B
Gross Income Growth
-22.97% +10.77% +43.09% +18.56%
Gross Profit Margin
+7.92% +8.23% +10.63% +11.48%
2022 2023 2024 2025 5-year trend
SG&A Expense
- - - -
-
Research & Development
- - - -
-
Other SG&A
- - - -
-
SGA Growth
- - - -
-
Other Operating Expense
- - - -
-
Unusual Expense
57.55M 45.75M (62.34M) 53.95M
EBIT after Unusual Expense
1.00B 1.13B 1.74B 1.94B
Non Operating Income/Expense
(10.03M) 18.04M (58.69M) 189.33M
Non-Operating Interest Income
378.00K 572.00K 1.43M 1.19M
Equity in Earnings of Affiliates
1.20M 874.00K 1.10M 1.00M
Interest Expense
127.27M 207.25M 187.53M 157.26M
Interest Expense Growth
+49.26% +62.84% -9.51% -16.14%
Gross Interest Expense
135.89M 231.67M 226.46M 190.85M
Interest Capitalized
8.62M 24.42M 38.92M 33.59M
Pretax Income
866.26M 940.43M 1.50B 1.97B
Pretax Income Growth
-33.02% +8.56% +59.28% +31.66%
Pretax Margin
+6.46% +6.58% +9.46% +11.36%
Income Tax
209.28M 221.12M 334.83M 460.96M
Income Tax - Current - Domestic
212.09M 232.57M 357.32M 394.57M
Income Tax - Current - Foreign
14.74M 6.50M 10.96M 15.65M
Income Tax - Deferred - Domestic
(16.04M) (21.32M) (32.14M) 44.72M
Income Tax - Deferred - Foreign
(1.51M) 3.37M (1.32M) 6.02M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.20M 874.00K 1.10M 1.00M
Other After Tax Income (Expense)
- (748.00K) (308.00K) (50.00K)
Consolidated Net Income
656.23M 719.00M 1.16B 1.51B
Minority Interest Expense
(18.63M) 1.51M 21.01M 22.39M
Net Income
674.86M 717.49M 1.14B 1.49B
Net Income Growth
-31.80% +6.32% +59.17% +30.36%
Net Margin Growth
+5.04% +5.02% +7.22% +8.57%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
674.86M 717.49M 1.14B 1.49B
Preferred Dividends
- - - -
-
Net Income Available to Common
674.86M 717.49M 1.14B 1.49B
EPS (Basic)
9.2297 10.3502 17.1597 23.4157
EPS (Basic) Growth
-23.03% +12.14% +65.79% +36.46%
Basic Shares Outstanding
73.12M 69.32M 66.55M 63.58M
EPS (Diluted)
9.1405 10.2315 16.8205 23.0957
EPS (Diluted) Growth
-22.69% +11.94% +64.40% +37.31%
Diluted Shares Outstanding
73.83M 70.13M 67.90M 64.46M
EBITDA
1.64B 1.74B 2.27B 2.61B
EBITDA Growth
-14.01% +6.11% +30.01% +15.27%
EBITDA Margin
+12.26% +12.21% +14.32% +15.05%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 250.294
Number of Ratings 21 Current Quarters Estimate 5.409
FY Report Date 03 / 2026 Current Year's Estimate 23.443
Last Quarter’s Earnings 5.88 Median PE on CY Estimate N/A
Year Ago Earnings 21.74 Next Fiscal Year Estimate 25.566
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 17 15
Mean Estimate 5.41 5.85 23.44 25.57
High Estimates 6.61 6.28 24.50 28.03
Low Estimate 4.76 5.40 22.33 23.75
Coefficient of Variance 8.12 4.28 2.42 3.96

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 6 7
OVERWEIGHT 3 3 3
HOLD 10 8 12
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Universal Health Services Inc. - UHS

Date Name Shares Transaction Value
Mar 12, 2026 Alan B. Miller Executive Chairman; Director 1,808,531 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $138.8 per share 251,024,102.80
Mar 12, 2026 Alan B. Miller Executive Chairman; Director 1,878,743 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $152.68 per share 286,846,481.24
Mar 12, 2026 Alan B. Miller Executive Chairman; Director 1,764,485 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $189.62 per share 334,581,645.70
Mar 12, 2026 Alan B. Miller Executive Chairman; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2026 Alan B. Miller Executive Chairman; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Nov 7, 2025 Marc Daniel Miller President and CEO; Director 353,054 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $138.8 per share 49,003,895.20
Nov 7, 2025 Marc Daniel Miller President and CEO; Director 443,054 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $152.68 per share 67,645,484.72
Nov 7, 2025 Marc Daniel Miller President and CEO; Director 311,296 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $225.3 per share 70,134,988.80
Nov 7, 2025 Marc Daniel Miller President and CEO; Director 50,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Nov 7, 2025 Marc Daniel Miller President and CEO; Director 50,425 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Universal Health Services Inc. in the News